Cargando…
Nanobody-Functionalized Cellulose for Capturing SARS-CoV-2
The highly transmissible severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 253 million people, claiming ∼5.1 million lives to date. Although mandatory quarantines, lockdowns, and vaccinations help curb viral transmission, there is a pressing need for cost-effective...
Autores principales: | Sun, Xin, Yang, Shaobo, Al-Dossary, Amal A., Broitman, Shana, Ni, Yun, Guan, Ming, Yang, Mengdi, Li, Jiahe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904043/ https://www.ncbi.nlm.nih.gov/pubmed/34985974 http://dx.doi.org/10.1128/aem.02303-21 |
Ejemplares similares
-
Screening and identification of an anti-PD-1 nanobody with antitumor activity
por: Zhang, Yanting, et al.
Publicado: (2023) -
Plant production of high affinity nanobodies that block SARS-CoV-2 spike protein binding with its receptor, human angiotensin converting enzyme
por: Pitino, Marco, et al.
Publicado: (2022) -
Development and Evaluation of Enzyme-Linked Viral Immune Capture Assay for Detection of SARS-CoV-2
por: Alharbi, Naif Khalaf, et al.
Publicado: (2022) -
Multifunctional Cellulose and Cellulose-Based (Nano) Composite Adsorbents
por: Shi, Ru-Jie, et al.
Publicado: (2022) -
CAMEL NANOBODIES NEUTRALIZE SARS-COV-2 VARIANTS
por: Hong, Jessica, et al.
Publicado: (2023)